Michelle Rudek, Pharm.D., Ph.D., is an associate professor of oncology at the Johns Hopkins University School of Medicine and director of the Analytical Pharmacology Core for the Johns Hopkins Kimmel Cancer Center.

Dr. Rudek studyies the pharmacokinetic-pharmacodynamic properties of anticancer agents, and her research is focused on oncology (preclinical studies and Phase I clinical trials/early phase drug development) and special populations within oncology (AIDS malignancy, and organ dysfunction).

She received her Pharm.D. and Ph.D. from the Medical College of Virginia and joined the faculty at Johns Hopkins in 2001.